Ex-Pfizer Inc. Chief Kindler Joins Team To Launch Baltimore Biotech
Published: Dec 31, 2013
A group of heavyweight biotech industry executives, including the former CEO of pharmaceutical giant Pfizer Inc., have formed a new Baltimore biotech company. Centrexion Corp. has raised a total of $23.4 million since its incorporation in February, according to recent Form D filings with the Securities and Exchange Commission. The Harbor East-based company’s management team includes Jeffrey B. Kindler, the former CEO of Pfizer (NYSE: PFI); Dr. James N. Campbell; and Kerrie L. Brady.
Help employers find you! Check out all the jobs and post your resume.